Related Experiment Video
Updated: Apr 3, 2026
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Primary Neuroendocrine Carcinoma of Breast
Khamar Jaha Banu1, Rajesh Ballal C1, Narendra Pai1
1Department of General Surgery, K S Hegde Hospital, Deralakate, Mangalore 575018 India.
Abstract:
Neuroendocrine differentiation can be identified in a subset of human breast carcinomas, either as scattered cells or as a predominant neuroendocrine component. Clinically, there are no notable or specific differences in presentation from other type of breast tumors. The diagnosis of neuroendocrine breast carcinoma relies mainly on histopathological examination and immunohistochemistry marker study. Treatment modalities are not different from those for the other conventional types. We report a case of primary neuroendocrine carcinoma of breast with relevant discussion on neuroendocrine tumor.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...